Valens Groworks — Valens Company — Q1 2022 Earnings Presentation
22 slides from Valens Groworks's earnings presentation, Apr 14, 2022
Slide 1: Q1 2022 Earnings
TSX: VLNS NASDAQ:VLNS Q1 2022 EARNINGS THEVALENSCOMPANY.COM
Slide 2: Notice to Recipient and Forward Looking Statements
NOTICE TO RECIPIENT This presentation (the “Presentation”) of The Valens Company Inc.(the “Company” or “The Valens Company” or “Valens”) is an overview only and does not contain all the information that a prospective investor may require to make investment decisions. This Presentation is for informa
Slide 3: Cautionary Note Regarding Future-Oriented Financial Information
Historical statements contained in this Presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. In this regard, certain financial information contained herein has been extracted from, or based upon, informat
Slide 4: Our Mission: Bringing the Benefits of Cannabis to the World
OUR MISSION BRINGING THE BENEFITS OF CANNABIS TO THE WORLD 4 TSX: VLNS | NASDAQ: VLNS
Slide 5: Table of Contents
5 TABLE OF CONTENTS 1. Key Performance Indicators 2. Quarterly Highlights 3. B2C and B2B Sales 4. Q1 2022 Earnings Highlights 5. Summary and Closing Remark 6. Q&A
Slide 6: Key Performance Indicators: Quarterly Success Scorecard
6 TSX: VLNS | NASDAQ: VLNS (1) Hifyre data for Ontario, Alberta, British Columbia and Saskatchewan as of February 2022 Note: Adjusted EBITDA is a Non-GAAP measure KEY PERFORMANCE INDICATORS QUARTERLY SUCCESS SCORECARD 1. Grow adult recreational market share in Canada by achieving top 5 in vapes, edi
Slide 7: Quarterly Highlights: Significant Progress Made in the Quarter
QUARTERLY HIGHLIGHTS SIGNIFICANT PROGRESS MADE IN THE QUARTER 7 (1) Based on Hifyre data for Alberta, British Columbia, Ontario and Saskatchewan as of February 2022 (2) Cash & equivalents includes cash and marketable securities of C$20.2MM as of February 28, 2022 as well as gross proceeds of C$32.3M
Slide 8: Provincial Sales: Growth in Provincial Sales Poised to Continue
PROVINCIAL SALES GROWTH IN PROVINCIAL SALES POISED TO CONTINUE 8 Market Share Rankings and Provincial Sales Growth(1) • In Q1, Valens became a top 10 ranked Licensed Producer in Canada, with retail sales growing by 311% year-over-year • Demonstrated strong momentum with one of the highest Y/Y and Q/
Slide 9: Provincial Sales: Cross Canada Penetration
9 PROVINCIAL SALES CROSS CANADA PENETRATION S H I N Y B UD • Exposure to 80%+ of the Canadian market, working to create deeper relationships with retailers to drive listings and sales • One of the highest acceptance rates for new listings, offering consumers the products they want at attractive pric
Slide 10: Provincial Sales: Selection of 2022 Targeted Innovation
PROVINCIAL SALES SELECTION OF 2022 TARGETED INNOVATION 10 TSX: VLNS | NASDAQ: VLNS FLOWER PRE-ROLL VAPE CONCENTRATES EDIBLES BEVERAGES PREMIUM • Flap Jacks 3.5g • Flap Jacks 7g • Platinum Cookies 3.5g • Platinum Cookies 7g • GRIMM Glue 3.5g • CNDYLND 14g • 1 x 1g CNDYLND • 1 x 1g Flap Jacks • 1 x 1g
Slide 11: Green Roads: Base Business Flat with New Products
56.3% GREEN ROADS BASE BUSINESS FLAT WITH NEW PRODUCTS SEEKING TO DRIVE MOMENTUM 11 TSX: VLNS | NASDAQ: VLNS • Q/Q revenue decline but margins remain strong ▪ Seasonally weak quarter (post Black Friday) ▪ Launch of brand campaign delayed programs ▪ Unsustainable online spend from competitors • New "
Slide 12: Green Roads U.S. Distribution Driven by High Margin Online Sales
GREEN ROADS U.S. DISTRIBUTION DRIVEN BY HIGH MARGIN ONLINE SALES 12 TSX: VLNS | NASDAQ: VLNS • Transition continues towards 60% + of revenue coming from the online channel ▪ Brand campaign live with new strategies launching ▪ Sophisticated e-commerce platform in place to manage growth • Retail busin
Slide 13: B2B Sales: Focus on Fewer, Bigger, Better
B2B SALES FOCUS ON FEWER, BIGGER, BETTER 13 TSX: VLNS | NASDAQ: VLNS Legacy B2B Business Working with many LPs and Brand Partners • Lack of consistency in order volumes • Higher quantity of customer touch points • Smaller order quantities • Disadvantaged by long term consolidation 13 New B2B Busines
Slide 14: Q1 2022 Earnings Highlights: Revenue Growth Driven by Provincial Sales
Q1 2022 EARNINGS HIGHLIGHTS REVENUE GROWTH DRIVEN BY PROVINCIAL SALES 14 • Significant progress made in the quarter, particularly in Provincial Sales (+36.7%) with the launch of Contraband and Versus ▪ B2B sales (+53.7%) were strong, albeit at lower margins as we moved through the consumption of hig
Slide 15: B2C Revenue Lines Exhibit Margin Expansion
Q1 2022 EARNINGS HIGHLIGHTS B2C REVENUE LINES EXHIBIT MARGIN EXPANSION 15 (1) Adjusted gross margin excludes the impact of inventory valuation allowance and is a Non-GAAP measure. Change in adjusted gross margin displayed for Q1 2022 compared to Q4 2021. Changes displayed in basis points (“bps”) sig
Slide 16: Gross Margin Decline and Advertising Investments Impacted EBITDA
Q1 2022 EARNINGS HIGHLIGHTS GROSS MARGIN DECLINE AND INVESTMENTS IN ADVERTISING & PROMOTION IMPACTED EBITDA 16 (1) Other Changes include other changes in SG&A expenses, depreciation and amortization, and other items in the adjusted EBITDA reconciliation (2) SG&A rate defined as SG&A expense as a per
Slide 17: Investments in the Quarter Drive Future Success
Q1 2022 EARNINGS HIGHLIGHTS INVESTMENTS IN THE QUARTER DRIVE FUTURE SUCCESS 17 A. Debt facility pay down and associated fees B. Acquisition of inventory to drive future brand launches C. Capex and strategic investments D. Restructuring costs, taxes and other non-operating cash changes TSX: VLNS | NA
Slide 18: Illustrative Working Capital Example
Q1 2022 EARNINGS HIGHLIGHTS ILLUSTRATIVE WORKING CAPITAL EXAMPLE 18 (1) Simplified and illustrative example of the cash conversion cycle for some of Valens flower products. Not representative of all product types within the Valens portfolio, nor of collection terms with all provincial distributors •
Slide 19: Integration Initiatives: First Wave of Cost Efficiencies Near Complete
INTEGRATION INITIATIVES FIRST WAVE OF COST EFFICIENCIES NEAR COMPLETE 19 We have now executed on approximately 95% of the first $10MM in cost efficiencies through operational and organizational changes that will drive the business towards becoming EBITDA positive in fiscal Q4 2022 TSX: VLNS | NASDAQ
Slide 20: Investment Thesis
1. One of the most innovative manufacturing platforms in Canada Fully built and comprehensive manufacturing and distribution platform which utilizes the latest forms of innovation and automation 2. Strategically positioned downstream from cultivation Use of contract growing partners combined with sp
Slide 21: Questions & Answers
QUESTIONS & ANSWERS 21 TSX: VLNS | NASDAQ: VLNS
Slide 22: Contact Us
CONTACT US TORONTO KELOWNA 96 Spadina Ave, Suite 400 Toronto, ON 230 Carion Rd Kelowna, BC EMAIL PHONE IR@TheValensCompany.com 1 647-956-8254 TSX: VLNS | NASDAQ: VLNS 22